EPA+DHA (SC401B)

eicosapentaenoic acid and docosahexaenoic acid · Sancilio and Company, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EPA+DHA (SC401B), covering 2016-11-25 to 2016-11-25. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy of EPA+DHA (SC401B) for Lowering Triglyceride Levels (≥ 500 mg/dL) [Phase 3]